Eledon Pharmaceuticals In... (ELDN)
NASDAQ: ELDN
· Real-Time Price · USD
2.55
-0.05 (-1.92%)
At close: Sep 23, 2025, 3:59 PM
-1.92% (1D)
Bid | 2.5 |
Market Cap | 152.7M |
Revenue (ttm) | 192K |
Net Income (ttm) | 14.64M |
EPS (ttm) | 0.65 |
PE Ratio (ttm) | 3.92 |
Forward PE | -2.5 |
Analyst | Buy |
Dividends | n/a |
Ask | 2.75 |
Volume | 1,072,102 |
Avg. Volume (20D) | 868,796 |
Open | 2.63 |
Previous Close | 2.60 |
Day's Range | 2.55 - 2.71 |
52-Week Range | 2.31 - 5.54 |
Beta | -0.12 |
Ex-Dividend Date | n/a |
About ELDN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELDN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELDN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.9%
Eledon Pharmaceuticals shares are trading lower. T...
Unlock content with
Pro Subscription
10 months ago
-11.41%
Eledon Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 EPS results.

2 months ago · https://www.marketscreener.com
Eledon Pharmaceuticals, Inc.(NasdaqCM:ELDN) added to Russell 3000 Growth IndexEledon Pharmaceuticals, Inc.(NasdaqCM:ELDN) added to Russell 3000 Growth Index